Clinical Laserthermia Systems Stock Price To Sales
| CLS-B Stock | SEK 3.98 0.26 6.99% |
Clinical Laserthermia Systems fundamentals help investors to digest information that contributes to Clinical Laserthermia's financial success or failures. It also enables traders to predict the movement of Clinical Stock. The fundamental analysis module provides a way to measure Clinical Laserthermia's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Clinical Laserthermia stock.
Clinical |
Clinical Laserthermia Systems Company Price To Sales Analysis
Clinical Laserthermia's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Clinical Laserthermia Price To Sales | 28.92 X |
Most of Clinical Laserthermia's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clinical Laserthermia Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Clinical Laserthermia Systems has a Price To Sales of 28.922 times. This is 35.15% higher than that of the Healthcare sector and notably higher than that of the Medical Devices industry. The price to sales for all Sweden stocks is 153.26% lower than that of the firm.
Clinical Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clinical Laserthermia's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clinical Laserthermia could also be used in its relative valuation, which is a method of valuing Clinical Laserthermia by comparing valuation metrics of similar companies.Clinical Laserthermia is currently under evaluation in price to sales category among its peers.
Clinical Fundamentals
| Return On Equity | -2.59 | |||
| Return On Asset | -0.66 | |||
| Operating Margin | (23.95) % | |||
| Current Valuation | 73.29 M | |||
| Shares Outstanding | 134.52 M | |||
| Shares Owned By Insiders | 9.70 % | |||
| Shares Owned By Institutions | 2.27 % | |||
| Price To Earning | (10.13) X | |||
| Price To Book | 4.26 X | |||
| Price To Sales | 28.92 X | |||
| Revenue | 2.25 M | |||
| Gross Profit | (3.63 M) | |||
| EBITDA | (54.42 M) | |||
| Net Income | (63.62 M) | |||
| Cash And Equivalents | 13.5 M | |||
| Cash Per Share | 0.39 X | |||
| Total Debt | 100 K | |||
| Debt To Equity | 3.20 % | |||
| Current Ratio | 3.61 X | |||
| Book Value Per Share | 0.18 X | |||
| Cash Flow From Operations | (66.17 M) | |||
| Earnings Per Share | (1.08) X | |||
| Target Price | 1.4 | |||
| Number Of Employees | 12 | |||
| Beta | 0.78 | |||
| Market Capitalization | 104.76 M | |||
| Total Asset | 66.74 M | |||
| Retained Earnings | (88 M) | |||
| Working Capital | 14 M | |||
| Current Asset | 22 M | |||
| Current Liabilities | 8 M | |||
| Net Asset | 66.74 M |
About Clinical Laserthermia Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clinical Laserthermia Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clinical Laserthermia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clinical Laserthermia Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clinical Stock Analysis
When running Clinical Laserthermia's price analysis, check to measure Clinical Laserthermia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinical Laserthermia is operating at the current time. Most of Clinical Laserthermia's value examination focuses on studying past and present price action to predict the probability of Clinical Laserthermia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinical Laserthermia's price. Additionally, you may evaluate how the addition of Clinical Laserthermia to your portfolios can decrease your overall portfolio volatility.